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Abstract
Aims: We evaluated the relationship between distribution of lesions in coronary tree and atherosclerotic renal artery stenosis (RAS).
Methods and results: Data collected prospectively on 500 consecutive patients who underwent simultaneous renal angiography 
­ following­coronary­angiography.­Overall­prevalence­of­RAS­was­26.2%­(131­patients).­Significant­($50% luminal diameter stenosis) 
RAS­was­present­in­70­patients­(14%).­In­346­individuals­of­the­study­population,­significant­CAD­was­present­(69.2%).­Significant­
RAS was more common (18.4%) in this group. Older age, higher intra-arterial systolic blood pressure (SBP) and pulse pressure (PP) 
at­the­time­of­catheterization,­and­3-vessel­coronary­artery­disease­(CAD)­were­associated­with­significant­RAS­in­univariate­analysis.­
Relationship­between­involved­locations­of­coronary­arteries­[Left­anterior­descending­(LAD),­left­circumflex­(LCX),­Right­Coronary­
Artery­(RCA),­and­their­ostio-proximal­portions]­and­RAS­were­significant­except­for­left­main­(LM)­disease.­In­multivariate­model,­
age­more­than­62­years,­SBP­greater­than­150­mmHg,­PP­in­excess­of­60­mmHg­and­RCA­involvement­were­independent­predictors­of­
significant­RAS.
Conclusion:­Simultaneous­renal­angiography­following­coronary­angiography­might­be­justified­in­patients­with­significant­RCA­
  disease who are older with increased levels of intra-arterial SBP and PP.
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Introduction
Atherosclerotic  renal  artery  stenosis  (RAS)  is  an 
important and frequently unrecognized contributor to 
refractory hypertension (HTN), ischemic nephropa-
thy, and cardiac destabilization syndromes (unstable 
angina,­flash­pulmonary­edema,­and­decompensated­
heart failure).1–5 Atherosclerotic RAS is a progressive 
disease leading to renal atrophy over time and chronic 
kidney disease despite control of HTN.6–13
Presence  and  severity  of  incidental  RAS  is  an 
independent predictor of mortality in   atherosclerotic 
patients  regardless  of  the  mode  of  treatment  of 
  underlying coronary artery disease.13–15
The prevalence of RAS has been reported to be in 
the range of 20–30 percent in high risk populations 
including patients with known atherosclerotic vascu-
lar disease elsewhere.16–18 In these patients invasive 
screening for RAS is highly cost-effective especially 
when done at the time of another invasive diagnostic 
procedure like cardiac catheterization, and may affect 
treatment strategies.19
Atherosclerosis  is  a  diffuse  process  but  affects 
certain  regions  of  the  vascular  bed  preferentially. 
The­association­between­extent­and­severity­of­CAD­
and RAS has been well established in most previous 
studies,12–14 but a few has been addressed the relation-
ship between the distribution of lesions in coronary 
tree and RAS.2,8,14
The­main­purpose­of­our­study­was­to­find­out­if­
any­association­exists.­In­parallel,­we­evaluated­the­
relationship  between  demographic  variables,  ath-
erosclerotic  risk  factors,  renal  function,  and  levels 
of intra-arterial pressures during catheterization and 
RAS.­In­conclusion,­we­postulated­that­these­findings­
might help decide in which group of patients screen-
ing­renal­angiography­could­be­justified­following­
coronary angiography.
Methods
Over a period of 12 months from November 2008, data 
collected prospectively on 500 consecutive patients 
who  underwent  simultaneous  renal  angiography 
  following coronary angiography in Shaheed Rajaie 
Cardiovascular­Medical,­and­Research­Center.
The indications for coronary and renal   angiography 
were at the discretion of the attending cardiologist. 
Demographic variables, laboratory data, and   history 
of  atherosclerotic  risk  factors  obtained  from  the 
patients’ medical record.
Patients  considered  hypertensive,  if  they  had  a 
  positive history of HTN who were under life style 
modification­ and/or­ medical­ treatment.­ Patients­
­ considered­diabetic­(DM)­as­either­currently­­ taking­
anti-diabetic  medications  or  having  more  than 
one fasting plasma glucose (FPG) $126­mg/dl­on­
­ laboratory­record.­Dyslipidemia­(DLP)­defined­if­the­
patient was under medical treatment for known dys-
lipidemia or any of the following laboratory criteria 
existed:­Fasting­low-density­lipoprotein­cholesterol­
(LDLc) $130­mg/dl,­high-density­lipoprotein­cho-
lesterol (HDLc) #40­mg/dl­in­men­and­#50­mg/dl­
in women or triglycerides $150­mg/dl.­Patients­con-
sidered  having  a  history  of  smoking  if  they  were 
  current or former smokers. A positive family history 
(FH)­established­based­on­a­known­history­of­CAD­
in­ a­ first­ degree­ relative­ male­ or­ female­ less­ than­
45­and­55­years­respectively.­Glomerular­filtration­
rate­(GFR)­estimated­by­the­four­variable­modifica-
tion­of­diet­in­renal­disease­(MDRD)­equation­using­
plasma creatinine concentration, age, and gender.
According to the catheterization laboratory routine 
practice, all of these patients underwent abdominal 
aortography following coronary angiography using a 
pigtail catheter and 10–20 degrees straight left ante-
rior oblique (LAO) projection with a pump injector at 
a­rate­of­15­ml/sec.­In­those­patients­for­whom­it­was­
difficult­to­evaluate­the­degree­of­stenosis­via­aortog-
raphy,  selective  renal  angiography  also  performed 
using  a  right  judkins  catheter  and  0–20  degrees 
straight  LAO  projections  with  hand  injection. 
By average, about 30–40 ml additional   contrast media 
were utilized which was either Ultravist-300   (Shering 
AG,  Germany)  or  Visipaque-320  (GE  Healthcare, 
  Ireland). No procedural related complications with 
either  method  reported.  Data  on  contrast-induced 
nephropathy­(CIN)­was­not­available.
Significant­RAS­defined­if­luminal-narrowing­$50 
percent­was­present.­Coronary­disease­considered­ostio-
proximal­if­it­observed­before­first­diagonal­or­septal­
branch­in­LAD­artery,­before­first­sizable­obtuse­mar-
ginal­(OM)­branch­in­LCX­artery­and­before­the­first­
bend­of­the­vessel­in­RCA.­All­angiograms­digitally­
recorded­at­15­frames/sec­speed­and­interpreted­at­a­con-
sensus of two interventional cardiology fellowships.relationship between distribution of coronary artery lesions and renal artery stenosis
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statistical Analysis
All  collected  data  entered  into  a  database  and 
  subsequently  analyzed  using  SPSS  software 
version 15.0 for windows (SPSS). The relationship 
between­ RAS­ and­ other­ variables­ was­ examined­
using    student’s  T-test  for  normal  continuous  vari-
ables­ and­ Chi-square­ test­ for­ categorical­ factors.­
Continuous­variables­that­revealed­significant­rela-
tionship with RAS in univariate analysis categorized 
according to their distributions and entered into the 
multivariate­ model.­ Numerical­ variables­ expressed­
as mean ± standard deviation (SD) and categorical 
factors as percentages. Finally, independent predic-
tors of RAS derived by multivariate stepwise logistic 
­ regression­analysis­and­expressed­as­odds­ratios­(OR)­
with­95%­confidence­interval­(CI).
P  value  of  0.05  or  less  considered  statistically 
significant.
Results
In these cohort of patients, 264 (52.8%) were male 
with­mean­age­of­59.6­± 10.1 years and 236 (47.2%) 
were female with mean age of 60.8 ± 8.7 years. As 
for  major  atherosclerotic  risk  factors,  373  patients 
(74.6%)­had­HTN,­219­patients­(43.8%)­were­diabet-
ics,­445­individuals­(89%)­had­DLP,­108­(21.6%)­of­
them were smoker and 37 subjects (7.4%) had a posi-
tive FH (Table 1).
Prevalence of RAS with any degree of   stenosis 
was­ 26.2%­ (131­ patients).­ Significant­ RA­ S­ was­
present in 70 patients (14%). It was unilateral in 
46­ patients­ (9.2%)­ and­ bilateral­ in­ 24­ (4.8%).­
In 26 (56%) of patients with unilateral disease, RAS 
was detected on left renal artery and in 20 patients 
(44%) right renal artery was involved. High-grades 
stenosis ($70% luminal narrowing) was present in 
45­(9%)­of­them­[37­(7.4%)­unilateral,­81­(1.6%)­
bilateral,­18­(49%)­on­the­left­side­and­19­(51%)­on­
the­right]­(Fig. 1).
Patients  with  high-grade  stenosis  underwent 
renal artery stenting at the same setting or differed 
intervention for another session. Patients with mod-
erate (50%–70%) stenosis referred to nephrologists 
for further assessment about intervention or medi-
cal­ therapy.­ In­ 346­ individuals,­ significant­ CAD­
was­ present­ (69.2%).­ Significant­ RAS­ was­ more­
common (18.4%, P , 0.001) in this group. In the 
remaining  154  patients  (30.8%)  with  either  nor-
mal­coronaries­or­insignificant­CAD,­six­subjects­
(1.2%)­had­significant­RAS­in­which­all­were­high-
grade­stenosis­(bilateral­in­one).­Significant­RAS­
was  more  common  in  patients  with  three  vessel 
CAD­compared­to­those­with­single­or­two­vessel­
CAD.­Relationships­between­involved­locations­of­
coronary­arteries­and­RAS­were­significant­except­
for­LM­disease­(See­Table 2).
Patients­ with­ significant­ RAS­ were­ older­ com-
pared­ to­ those­ without­ significant­ disease.­ Neither­
sex­nor­other­atherosclerotic­risk­factors­showed­any­
association­with­significant­RAS.­Borderline­relation-
ships­observed­between­significant­RAS,­serum­crea-
tinine, and eGFR levels (Table 1). Because almost all 
patients were receiving statins, which has modest effect 
on HDLc (less than 10% increase in HDLc) compared 
Table 1. Patients’ clinical characteristics.
Variable Total  
(n = 500)
RAs $ 50% 
(n = 70)
RAs , 50% or 
normal (n = 430)
P value
Age 60.1 ± 9.4 63.1 ± 8.7 59.5 ± 9.9 0.003
Female (n) (%) 236 (47.2) 35 (50.0) 201 (46.7) 0.613
Male (n) (%) 264 (52.8) 35 (50.0) 229 (53.2) 0.613
hypertension (n) (%) 373 (74.6) 58 (82.8) 315 (73.2) 0.087
Diabetes mellitus (n) (%) 219 (43.8) 28 (40.0) 191 (44.0) 0.490
Dyslipidemia (n) (%) 445 (89.0) 65 (92.8) 380 (88.3) 0.266
Smoking (n) (%) 108 (21.6) 13 (18.5) 95 (22.0) 0.507
Positive family history (n) (%) 37 (7.4) 3 (4.2) 34 (7.9) 0.283
Serum creatinine (mg/dl) (mean ± SD) 1.10 ± 0.30 1.17 ± 0.37 1.09 ± 0.29 0.095
estimated gFr (ml/min/1.73 m2) (mean ± SD) 68.2 ± 20.5 64.8 ± 23.9 68.8 ± 19.9 0.050
hDLc (mg/dl) (mean ± SD) 38.6 ± 12.5 36.4 ± 1.2 39 ± 12.7 0.104
Abbreviation: rAS, renal artery stenosis.Salehi et al
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with­ other­ components­ of­ lipid­ profile,1  only  this 
parameter statistically analyzed.
Mean­ intra-arterial­ systolic,­ diastolic­ and­ pulse­
pressures during catheterization were 172.8 ± 30.7 
vs. 161.6 ±­29.2­mmHg­for­systolic­BP,­85.1­± 14 
vs. 78.8 ± 21.5 for diastolic BP and 87.7 ± 23.7 vs. 
78.8 ±­21.5­for­pulse­pressure­with­significant­RAS­
compared  to  those  without  demonstrating  a  good 
relationship between systolic and pulse pressures but 
not diastolic BP and RAS.
At  the  end,  by  multivariate  logistic  regression 
analysis­age­more­than­62­years­(OR­2.12;­95%­CI­
1.16 to 3.48, P = 0.013), SBP greater than 150 mmHg 
(OR =­3.19;­95%­CI­1.57­to­6.46,­P = 0.001), PP 
in­excess­of­60­(OR­=­3.82;­95%­CI­1.11­to­13.09,­
P  =­ 0.033)­ and­ RCA­ involvement­ (OR­ =  3.76; 
95%­CI­1.89­to­7.48,­P , 0.001) were independent 
­ predictors­ of­ ­ significant­ RAS.­ LAD­ artery­ ­ disease­
showed­ borderline­ significance­ (OR­ 2.12;­ 95%­
CI­0.94­to­4.79;­P =­0.069).­Results­of­the­models­for­
RAS $ 70% were almost similar to RAS $ 50% in 
both univariate and multivariate analyses.
Discussion
Prevalence of RAS with different severities and of 
bilateral RAS in this cohort of patients undergoing 
coronary  angiography  is  within  the  range  of  most 
other studies.
Our study showed no difference in patients with sig-
nificant­RAS­compared­to­those­without­with­respect­
to­major­atherosclerotic­risk­factors­except­for­age.­
This­may­reflect­that­traditional­risk­factors­have­a­
limited­potential­for­predicting­RAS.­­ Dzielińska­et­al5 
and Wang et al12 were reported similar results, but 
considerable variability seen in many other studies.
In  our  study,  age  more  than  62  years  was  an 
  independent predictor of RAS. In a number of   studies, 
this  issue  addressed  with  different  thresholds,  in 
which it was more than 60 years at a minimum.6,9 We 
also  found  borderline  relationships  between  serum 
creatinine,  eGFR  levels,  and  RAS.  In  most  stud-
ies­ reduced­ levels­ of­ eGFR­ (specifically­ less­ than­
60­ml/min/1.73­m2) discovered to be an independent 
predictor­of­significant­RAS.
Bearing in mind that not all patients with even 
severe  RAS  have  uncontrolled  HTN,  renal  fail-
ure or other clinical clues1,12 and the fact that well 
proven  anti-atherothrombotic  medications  which 
block   rennin-angiotensin system may act as a two 
edged­ sword­ in­ the­ presence­ of­ significant­ but­
Table 2. Catheterization characteristics.
Variable Total  
(n = 500)
RAs $ 50 
(n = 70)
RAs , 50% or  
normal (n = 430)
P value
Significant CAD 346 (69.2) 64 (91.4) 282 (65.5) ,0.001
extent of CAD 
  normal coronary or minimal CAD 
  1VD 
  2VD 
  3VD
 
154 (30.8) 
77 (15.4) 
102 (20.4) 
167 (33.4)
 
6 (8.5) 
7 (48.5) 
17 (24.2) 
40 (57.1)
 
148 (34.4) 
70 (37) 
85 (19.5) 
127 (29.5)
 
,0.001 
0.213 
0.424 
,0.001
LAD 311 (62.2) 60 (85.7) 251 (58.3) ,0.001
LCX 242 (48.4) 47 (67.1) 195 (45.3) 0.001
rCA 229 (45.8) 54 (77.1) 175 (40.6) ,0.001
Ostio-proximal LAD 164 (32.8) 32 (45.7) 132 (30.6) 0.014
Ostio-proximal LCX 86 (17.2) 20 (28.5) 66 (15.3) 0.007
Ostio-proximal rCA 111 (22.2) 25 (35.7) 86 (20) 0.003
Left main disease 26 (5.2) 6 (8.5) 20 (4.6) 0.171
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Figure 1. Severity and sidedness (left, right, and bilateral) of renal artery 
lesions.relationship between distribution of coronary artery lesions and renal artery stenosis
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  clinically unsuspected bilateral RAS1,3 underscores 
the need to step beyond traditional screening for 
RAS.­ ­ Additionally­ hemodynamically­ significant­
RAS may have several deleterious systemic effects 
through activating this system, which may acceler-
ate atherogenesis and contribute to cardiovascular 
events.13,14
There was a good relationship between   intra-arterial 
systolic and pulse pressures and RAS, which is in agree-
ment­with­study­of­Weber-Mzell­et­al8 and Rihal et al.18 
In our study, systolic BP above 150-mmHg and pulse 
pressure­in­excess­of­60­mmHg­found­to­be­indepen-
dent­predictors­of­significant­RAS.­Wide­pulse­pres-
sure­may­simply­reflect­more­advanced­arteriosclerosis­
and renal disease and in a recent published study of 
Dieter et al,20 pulse pressure .100 mmHg was shown 
a powerful predictor of poor outcome following renal 
angioplasty­and­stenting.­We­found­highly­significant­
relationships  between  atherosclerotic  involvement 
of­LAD,­LCX,­and­RCA­and­RAS,­which­remained­
significant­in­their­ostio-proximal­segments;­this­was­
not­true­for­significant­LM­disease.­As­for­number­of­
coronaries­involved,­patients­with­three­vessels­CAD­
showed strong relationship with RAS and those with 
normal­coronaries­or­insignificant­CAD­had­a­potent­
negative association with RAS. Interestingly in mul-
tivariate­model,­three­vessels­CAD­no­longer­seen­as­
an­independent­predictor­of­RAS­while­RCA­involve-
ment was a strong independent predictor of RAS and 
LAD artery disease showed borderline   relationship. 
As  far  as  we  know  this  independent  relationship 
between­atherosclerotic­disease­of­RCA­and­signifi-
cant RAS not been reported before.
The predilections of certain sites in vascular sys-
tem to develop atheroma are clear.1 Atherosclerotic 
RAS predominantly affects the aorto-ostial segment,1 
but  relationship  between  distribution  of  coronary 
artery lesions and segments involved has not been 
addressed­extensively.
In­ a­ study­ by­ Weber-Mzell­ et­ al,8­ LAD,­ LCX,­
and­ RCA­ stenosis­ were­ more­ frequent­ in­ patients­
with­ ­ significant­ RAS­ but­ in­ multivariate­ analysis,­
  having .2­significant­coronary­lesions­recognized­as­
an   independent predictor of RAS. In another study 
by­Conlon­et­al,14 LAD disease was more frequent 
in patients with RAS $ 75%. There was no relation-
ship  between    anatomical    distribution  of  coronary 
artery­lesions­(proximal,­mid­or­distal­portions)­and­
RAS in a study by Danesh et al,2 but two and 3-vessel 
  coronary disease reported as an independent predic-
tor­of­significant­RAS.
Although the therapeutic implications of inciden-
tally detected RAS has been remained controversial 
until now21 it may be valuable to be aware of this 
condition given the progressive nature of the disease, 
the precautions in prescribing angiotensin antagonists 
and possibly the need to revascularization in appro-
priately selected cases.
Given  the  considerable  drawbacks  of  nonin-
vasive  imaging  techniques1,2,13  and  safety  of  renal 
angiography13,16,17  recognizing  potential  candidates 
for screening of RAS based on readily available vari-
ables at the time of cardiac catheterization is important 
from a practical point of view. Patients with inciden-
tal RAS may deserve aggressive medical treatment 
and more close follow-up.
conclusion
Simultaneous renal angiography at the time of cor-
onary­ angiography­ might­ be­ justified­ in­ patients­
older  than  62  years,  with  increased  intra-arterial 
systolic pressure ($150 mmHg) and pulse pressure 
($60)­and­RCA­disease­in­the­absence­of­traditional­
  clinical clues.
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